Adam Snook

44PUBLICATIONS

90CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseases

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (44)

Sort by Publication Date:

|Jun 03, 2026

Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy.

|May 26, 2026

In-Use Stability and Device Compatibility Define Clinically Actionable Handling Limits for a GMP-Produced Attenuated <i>Listeria monocytogenes</i> Vaccine Expressing GUCY2C.

|Feb 23, 2026

DSG2-Directed CAR-T Cells Safely and Universally Eliminate Solid Tumors.

Adam Snook, Robert Carlson, Lindsay Weil

|Feb 20, 2026

Could GUCY2C-targeted pharmacotherapy be effective in treating colorectal cancer?

Scott A Waldman, Adam E Snook

|Oct 03, 2025

Immunotherapy for precision medicine in colorectal cancer.

Miao Cao, Michael Xu, Zinah Bairmani

|Jul 29, 2025

Cancer Vaccination and Immune-Based Approaches in Pancreatic Cancer.

Matthew Bloom, Ali Raza Shaikh, Zhengyang Sun

Pageof 8

Frequent Collaborators

11 joint publications

Scott Waldman

Babar Bashir

Robert D Carlson

Lara Cheslow

Trevor R Baybutt

Joshua R Barton

Ross E Staudt

Ariana A Entezari

Richard J Smeyne

Adi Caspi

Frequent Collaborators

11 joint publications

Scott Waldman

6 joint publications

Babar Bashir

6 joint publications

Robert D Carlson

4 joint publications

Lara Cheslow